Prostate cancer — all decisions

The appeal for service connection for prostate cancer and an acquired psychiatric condition was dismissed due to a pending Higher Level Review (HLR) request.

The Veteran's eligibility for specially adapted housing is granted due to his service-connected disabilities, specifically prostate cancer and metastatic bone cancer, which have rendered him unable to walk.

The Board denied service connection for a thyroid disability and prostate cancer, as the evidence did not support a medical nexus to the Veteran's military service.

The Board remands the claims for service connection for prostate cancer and a back condition due to pre-decisional duty to assist errors.

The Board denied the veteran's appeal for service connection claims due to untimely filings and lack of good cause.

The Board remands the claims for service connection for various disabilities, including foot, ankle, knee, elbow, leg varicose veins, colon cancer, prostate disability, and psychiatric disability, to correct pre-decisional duty to assist omissions.

The Board dismissed the Veteran's motion for revision based on clear and unmistakable error (CUE) in an April 2022 rating decision, as it was not properly raised with the AOJ first.

The Veteran was granted a 10 percent initial rating for hypertension and special monthly compensation at the rate authorized by 38 U.S.C. § 1114(m), (n), and (r)(1) effective from August 10, 2022, to November 7, 2024.

The Board denied service connection for multiple conditions, including hyperlipidemia, low testosterone, epididymitis, ED, prostatectomy, a mass of the parotid gland, prostate cancer, stress urinary incontinence, and other related conditions.

The Board denied increased ratings for various service-connected conditions, including prostate cancer, left lung residuals, tinnitus, hearing loss, erectile dysfunction, and abdominal scar. Service connection was granted for headaches secondary to tinnitus.

The appeal was dismissed due to the Veteran's death while it was pending.

The Veteran's claim for a disability evaluation in excess of 60 percent for prostate cancer residuals with voiding dysfunction was denied, while his TDIU claim beginning on August 28, 2015, was granted.

The Board granted a separate initial 20 percent rating for right knee meniscal tear based on limitation of knee flexion, and an initial 60 percent rating for arteriosclerotic heart disease. It also granted TDIU due to service-connected residuals of prostate cancer.

The Board denied the restoration of a 100 percent rating for prostate cancer, effective February 1, 2025, due to an improvement in the Veteran's condition.

The Board denied an increased rating in excess of 40 percent for residuals of prostate cancer and remanded the issue of a compensable disability rating for incisional hernia status post prostatectomy.

The Board granted increased ratings for dermatitis and central serous chorioretinopathy, while denying restoration of the rating for prostate cancer and granting SMC for loss of a creative organ.

The Board remands the claims for service connection for prostate cancer, erectile dysfunction, and residuals of left rib cage contusion to obtain a new VA medical opinion.

The appeal for service connection for prostate cancer, hearing loss, and glaucoma is dismissed as there are no remaining questions of law or fact to resolve.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of exposure to herbicide agents during service and that the Veteran's prostate cancer did not have its onset in service or within a year of discharge from service.

The appeal was dismissed due to the Veteran's death while it was pending.